- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01394380
Reduction of Sweetened Beverages and Intrahepatic Fat (REDUCS)
Effects of a Reduction of Sweetened Beverages Consumption in Overweight High Consumers on Cardiometabolic Risk Factors
The study will enroll 68 overweight male and female subjects with a high (> 2 3dl-can soda/day) consumption of sweetened beverage per day. After a run-in period of 4 weeks, subjects will be randomized to either a 12-week intervention arm in which sweetened beverages will be replaced by artificially sweetened, calorie-free beverages, or to a control arm. The following measurements will be performed at the end of the run-in period and at the end of the intervention period
- intrahepatic fat concentration
- visceral fat volume
- changes in day-long metabolic profile from baseline(plasma glucose, insulin, and triglyceride concentrations)
- changes in food intake and daily energy, carbohydrate and sugars intake from baseline
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
VD
-
Lausanne, VD, Switzerland, CH-1011
- Clinical Research Center, CHUV
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- gender male or female
- body mass index (BMI) > 27 kg/m2 consumption of > 2 3dl-can regular soda/day
- low to moderate physical activity (< 60 min walking/day; < 3 exercise session/week
Exclusion Criteria:
- diabetes mellitus
- liver, kidney or heart disease
- any current drug treatment
- contra-indications to MR examination (pacemaker, foreign bodies,etc)
- pregnancy or planned pregnancy
- active weight gain or weight loss (weight change > 4 kg in the past 12 months)
- consumption of drugs or illicit substances
- consumption of more than 10g alcohol/day
- vegetarians or subjects on special diets
Study Plan
How is the study designed?
Design Details
- Primary Purpose: PREVENTION
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: artificially sweetened beverages
subjects will be required to consume only artificially-sweetened sodas, water, tea or coffee
|
subjects will be allowed unlimited consumption of calorie-free, artificially-sweetened sodas, water, tea or coffee
|
|
NO_INTERVENTION: regular sodas
subjects will continue their usual consumption of sweetened sodas
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
changes in intrahepatic fat concentration
Time Frame: at the end of run-in and after 12 weeks intervention/control
|
intrahepatic fat content measured by 1H-MRS
|
at the end of run-in and after 12 weeks intervention/control
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
changes in visceral fat volume
Time Frame: at the end of run-in and after 12 weeks of intervention/control
|
Visceral fat volume measured by MRI
|
at the end of run-in and after 12 weeks of intervention/control
|
|
changes in day-long metabolic profile
Time Frame: at the end of run-in and after 12 weeks of intervention/control
|
Plasma glucose, insulin, non-esterified fatty acids, and triglycerides will be measured at 2-hourly intervals between 7:00 am and 5:00 pm.
Participants will be fed standardized meals and either sweetened or artificially-sweetened beverages according to randomization
|
at the end of run-in and after 12 weeks of intervention/control
|
|
changes in food intake from baseline
Time Frame: at the end of the run-in period and after 6, and 12 weeks of intervention/control
|
Total energy intake, total carbohydrate intake, and total sugars intake will be evaluated by 3-day food record
|
at the end of the run-in period and after 6, and 12 weeks of intervention/control
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Luc Tappy, MD, Department of Physiology, University of Lausanne
Study record dates
Study Major Dates
Study Start
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 171/11
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | Obesity and Obesity-related Medical ConditionsUnited States
-
Central Hospital, Nancy, FranceNot yet recruiting
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsCompletedOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
The Hospital for Sick ChildrenCompleted
-
Ihuoma EneliCompletedObesity, ChildhoodUnited States
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | GLP-1 | Obesity and Obesity-related Medical Conditions | Ablation TechniquesUnited States
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
Clinical Trials on artificially sweetened sodas
-
University of Colorado, Colorado SpringsRecruitingMenstrual IrregularityUnited States
-
Instituto de Nutrición y Tecnología de los AlimentosUnknown
-
Monica Flores-MuñozInstituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran; Universidad...Completed
-
Harvard School of Public Health (HSPH)CompletedBiomarkersUnited States
-
University of LausanneCompletedNormal SubjectsSwitzerland
-
University of California, IrvineNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); University...CompletedType 2 DiabetesUnited States
-
Fred Hutchinson Cancer CenterNational Heart, Lung, and Blood Institute (NHLBI); University of WashingtonCompletedObesity | Cardiovascular Disease | Type 2 Diabetes Mellitus | Intestinal Permeability | Low-grade Chronic InflammationUnited States
-
University of California, DavisRecruiting
-
University of Missouri-ColumbiaCompletedInsulin Sensitivity | Insulin ToleranceUnited States
-
University of OklahomaNational Institute on Drug Abuse (NIDA); American University of Beirut Medical... and other collaboratorsCompletedWaterpipe Smoking | Smoking, HookahUnited States